Brain tumor immunotherapy /
It is now clear from basic research and clinical trials that immunotherapy for brain tumors is feasible, can evoke relevant biologic responses, and can yield important insights into human biology. In Brain Tumor Immunotherapy, an authoritative panel of researchers and clinicians critically reviews t...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2001]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Introduction to the disease
- Neuropathology and molecular pathogenesis of primary brain tumors
- Epidemiology of primary brain tumors
- Current therapy for primary brain tumors
- Introduction to immunotherapy of brain tumors
- Immunostimulation and immunomodulation of brain tumors
- Biological principles of brain tumor immunotherapy
- Adoptive cellular immunotherapy of brain tumors
- Systemic T-cell immunotherapy for brain tumors
- Cytotoxic T-lymphocytes reactive to patient major histocompatibility complex proteins for therapy of brain tumors
- Autologous vaccine and adoptive cellular immunotherapy as treatment for brain tumors
- Antibody-mediated immunotherapy of brain tumors
- Anti-idiotype immunotherapy strategies for brain tumors
- Radiolabeled antibodies for therapy of brain tumors
- Immunotoxin therapy of brain tumors
- Antibodies to adhesion molecules for immunotherapy of brain tumors
- Tumor vaccines and other strategies
- Cytokine-based immuno-gene therapy for brain tumors
- Downregulation of transforming growth factor [beta] as therapeutic approach for brain tumors
- Dendritic cell immunotherapy for brain tumors
- Death ligand/death receptor-mediated apoptosis for treatment of brain tumors
- Combining radiation therapy with immunotherapy for treatment of brain tumors.